Assenagon Asset Management’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
PCM
AAM
WCMNY
PWAM
Assenagon Asset Management's AMED Position: Q3 2023 in Review
Assenagon Asset Management sold out of Amedisys (AMED) in Q3 2023, closing a stake of 61,563 shares — an estimated $5.63M sold.
Assenagon Asset Management first reported a position in AMED in Q3 2017 and held it in 16 quarters. The position peaked at $47M in Q3 2020. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.
- Assenagon Asset Management reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
- Assenagon Asset Management sold 61,563 Amedisys shares in Q3 2023, an estimated $5.63M.
- Assenagon Asset Management first reported a position in Amedisys in Q3 2017 and held it in 16 quarters.
- Assenagon Asset Management's Amedisys position peaked at $47M in Q3 2020.
- 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.
Based on Assenagon Asset Management's 13F filing for Q3 2023, filed 6 Nov 2023.